155 related articles for article (PubMed ID: 4508750)
1. Bioavailability and digoxin.
N Z Med J; 1972 Sep; 76(484):203. PubMed ID: 4508750
[No Abstract] [Full Text] [Related]
2. Bioavailability of digoxin tablets.
Lindenbaum J
Pharmacol Rev; 1973 Jun; 25(2):229-37. PubMed ID: 4581042
[No Abstract] [Full Text] [Related]
3. The bioavailability of digoxin.
Lancet; 1972 Aug; 2(7772):311-2. PubMed ID: 4115037
[No Abstract] [Full Text] [Related]
4. Biological availability of digoxin.
Shaw TR
Br Heart J; 1973 May; 35(5):554-5. PubMed ID: 4577277
[No Abstract] [Full Text] [Related]
5. Non-equivalence of digoxin tablets.
Reissell P; Manninen V; Ojala K; Karjalainen J
Ann Clin Res; 1974; 6(0):suppl 11:4-8. PubMed ID: 4853359
[No Abstract] [Full Text] [Related]
6. Dissimilarities of digoxin.
Goldfinger SE
N Engl J Med; 1971 Dec; 285(24):1376-7. PubMed ID: 5121194
[No Abstract] [Full Text] [Related]
7. Variation in the biological availability of digoxin.
Shaw TR; Howard MR; Hamer J
Lancet; 1972 Aug; 2(7772):303-7. PubMed ID: 4115034
[No Abstract] [Full Text] [Related]
8. Bioavailability of digoxin in capsules.
Padeletti L; Brat A
Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):320-2. PubMed ID: 669878
[TBL] [Abstract][Full Text] [Related]
9. Variation in biologic availability of digoxin from four preparations.
Lindenbaum J; Mellow MH; Blackstone MO; Butler VP
N Engl J Med; 1971 Dec; 285(24):1344-7. PubMed ID: 5121186
[No Abstract] [Full Text] [Related]
10. Proceedings: Influence of formulation on absorption and clinical effect of digoxin.
Shaw TR; Howard MR; Hamer J
Br Heart J; 1974 Apr; 36(4):400. PubMed ID: 4841478
[No Abstract] [Full Text] [Related]
11. [Clinical study of the biological availability of lanatoside C and digoxin in long-term tests].
Bodem G; Ochs H; Hahn E; Dengler HJ
Schweiz Med Wochenschr; 1977 May; 107(19):658-66. PubMed ID: 867012
[TBL] [Abstract][Full Text] [Related]
12. Biological availability of digoxin from Lanoxin produced in the United Kingdom.
Johnson BF; Fowle AS; Lader S; Fox J; Munro-Faure AD
Br Med J; 1973 Nov; 4(5888):323-6. PubMed ID: 4758424
[TBL] [Abstract][Full Text] [Related]
13. Digoxin bioavailability: formulations and rates of infusions.
Marcus FI; Dickerson J; Pippin S; Stafford M; Bressler R
Clin Pharmacol Ther; 1976 Sep; 20(3):253-9. PubMed ID: 954346
[TBL] [Abstract][Full Text] [Related]
14. Influence of soft gelatin on digoxin absorption.
O'Grady J; Johnson BF; Bye C; Sabey GA
Br J Clin Pharmacol; 1978 May; 5(5):461-3. PubMed ID: 656286
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of digoxin bioavailability in single-dose studies.
Greenblatt DJ; Duhme DW; Koch-Weser J; Smith TW
N Engl J Med; 1973 Sep; 289(13):651-4. PubMed ID: 4727968
[No Abstract] [Full Text] [Related]
16. [Bioavailability of digoxin in capsules and tablets and correlated indices of myocardial function in 9 heart disease patients].
Astorri E; La Canna G; Bianchi G; Assanelli D; Lombardi F; Dei Cas L
Boll Soc Ital Cardiol; 1978; 23(6):987-94. PubMed ID: 261884
[No Abstract] [Full Text] [Related]
17. Dissolution-rates and bioavailability of digoxin tablets.
Fraser EJ; Leach RH; Poston JW; Bold AM; Culank LS; Lipede AB
Lancet; 1973 Jun; 1(7816):1393. PubMed ID: 4122785
[No Abstract] [Full Text] [Related]
18. Some aspects of the influence of formulation on the bioavailability of drugs from solid dosage forms.
Corrigan OI; Timoney RF
Ir J Med Sci; 1974 Jul; 143(4):197-207. PubMed ID: 4605123
[No Abstract] [Full Text] [Related]
19. Digoxin preparations: variation in biological availability.
McCredie RM; Cody DV; Mackie AM; Ng KK; Worner FL; Chow M; Milstead G
Med J Aust; 1973 Nov; 2(20):922-5. PubMed ID: 4765886
[No Abstract] [Full Text] [Related]
20. Recognition of variable bioavailability as an international problem: a review of the earlier studies.
Munro-Faure AD; Fowle AS; Fox J; Johnson BF; Lader S
Postgrad Med J; 1974 Nov; 50 Suppl 6():14-8. PubMed ID: 4459882
[No Abstract] [Full Text] [Related]
[Next] [New Search]
